cyclosporine
Showing 1 - 25 of 338
Healthy Trial in New Haven (PF-07081532, Cyclosporine, Itraconazole)
Recruiting
- Healthy
- PF-07081532
- +2 more
-
New Haven, ConnecticutNew Haven Clinical Research Unit
Mar 2, 2023
Severe Aplastic Anemia Trial run by the NHLBI (Eltrombopag, Cyclosporine, Horse-Anti-thymocyte-Globulin)
Recruiting
- Severe Aplastic Anemia
- Eltrombopag
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 27, 2023
Healthy Trial in Singapore (Midazolam, LY3502970, Cyclosporine)
Recruiting
- Healthy
- Midazolam
- +2 more
-
Singapore, SingaporeLilly Centre for Clinical Pharmacology
Nov 23, 2022
Primary Membranous Nephropathy Trial (MIL62, Cyclosporine)
Not yet recruiting
- Primary Membranous Nephropathy
- MIL62
- Cyclosporine
- (no location specified)
May 16, 2023
DRESS Syndrome, Drug-Induced Hypersensitivity Syndrome Trial in Los Angeles (Cyclosporine, Methylprednisolone and Prednisone)
Enrolling by invitation
- DRESS Syndrome
- Drug-Induced Hypersensitivity Syndrome
- Cyclosporine
- Methylprednisolone and Prednisone
-
Los Angeles, CaliforniaUSC
May 7, 2022
Dry Eye Trial in Guangzhou (Cyclosporine, oculus keratograph, in vivo laser confocal microscopy, Functional slit lamp
Recruiting
- Dry Eye
- Cyclosporine
- oculus keratograph, in vivo laser confocal microscopy, Functional slit lamp biomicroscopy
-
Guangzhou, Guangdong, ChinaZhongshan Ophthalmic Center, Sun Yat-sen University
Feb 9, 2022
COVID-19 Trial in Philadelphia (Cyclosporine)
Completed
- COVID-19
- Cyclosporine
-
Philadelphia, PennsylvaniaUniversity of Pennsylvania
Jan 7, 2022
GVHD in Eye Trial in Beijing (Cyclosporine, tacrolimus)
Completed
- Graft Versus Host Disease in Eye
- Cyclosporine
- tacrolimus
-
Beijing, Beijing, ChinaPeking University Third Hospital
Mar 14, 2022
Severe Aplastic Anemia Trial in Worldwide (eltrombopag, Cyclosporine)
Completed
- Severe Aplastic Anemia
- eltrombopag
- Cyclosporine
-
Ribeirao Preto, SP, Brazil
- +19 more
Jun 29, 2022
Recurrent Hodgkin Lymphoma, Refractory Hodgkin Lymphoma Trial in Duarte (Brentuximab Vedotin, Cyclosporine, Pharmacokinetic
Active, not recruiting
- Recurrent Hodgkin Lymphoma
- Refractory Hodgkin Lymphoma
- Brentuximab Vedotin
- +4 more
-
Duarte, CaliforniaCity of Hope Medical Center
Feb 17, 2022
SARS (Disease) Trial in Houston (Cyclosporine, Standard of Care Treatment)
Recruiting
- SARS (Disease)
- Cyclosporine
- Standard of Care Treatment
-
Houston, TexasBaylor College of Medicine
Oct 26, 2021
Acute Leukemia of Ambiguous Lineage, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia Trial in Seattle (procedure, drug,
Not yet recruiting
- Acute Leukemia of Ambiguous Lineage
- +8 more
- Biospecimen Collection
- +12 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Aug 22, 2023
Primary Membranous Nephropathy Trial in Beijing (MIL62, Cyclosporine)
Recruiting
- Primary Membranous Nephropathy
- MIL62
- Cyclosporine
-
Beijing, Beijing, ChinaPeking University First Hospital
May 26, 2022
Primary Autoimmune Hemolytic Anemia Trial in Assiut,, Assiut (Cyclosporine, Rituximab)
Recruiting
- Primary Autoimmune Hemolytic Anemia
- Cyclosporine
- Rituximab
-
Assiut,, Assiut, Egypt
- +1 more
Oct 20, 2021
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Aggressive Non-Hodgkin Lymphoma Trial in Seattle (Allogeneic Hematopoietic
Recruiting
- Acute Lymphoblastic Leukemia
- +16 more
- Allogeneic Hematopoietic Stem Cell Transplantation
- +4 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Dec 1, 2022
Dry Eye Trial in Pittsburgh (Cyclosporine, Artificial tear)
Not yet recruiting
- Dry Eye
- Cyclosporine
- Artificial tear
-
Pittsburgh, PennsylvaniaUPMC Eye Center
Jan 5, 2022
Refractory Non Hodgkin Lymphoma, Relapsed Non Hodgkin Lymphoma Trial in Sacramento (biological, radiation, procedure, drug)
Active, not recruiting
- Refractory Non Hodgkin Lymphoma
- Relapsed Non Hodgkin Lymphoma
- rituximab
- +7 more
-
Sacramento, CaliforniaUniversity of California Davis
Nov 28, 2022
Aplastic Anemia, de Novo Myelodysplastic Syndrome, Myelodysplastic Syndrome Trial in Houston (Anti-Thymocyte Globulin,
Recruiting
- Aplastic Anemia
- +3 more
- Anti-Thymocyte Globulin
- +4 more
-
Houston, TexasM D Anderson Cancer Center
Dec 1, 2021
Myeloproliferative Disorders, Acute Myelogenous Leukemia, Chronic Myelogenous Leukemia Trial run by the NHLBI (T-cell replete
Completed
- Myeloproliferative Disorders
- +4 more
- T-cell replete PBPC allograft
- +3 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Oct 12, 2022
Drug Drug Interaction Trial in Hachioji-shi (SyB V-1901, Cyclosporine)
Completed
- Drug Drug Interaction
- SyB V-1901
- Cyclosporine
-
Hachioji-shi, Tokyo, JapanResearch Site
Apr 25, 2021
Hematologic Malignancy, Myeloid Malignancy Trial in Memphis (Ruxolitinib, Mesna, Anti-thymocyte globulin (ATG))
Recruiting
- Hematologic Malignancy
- Myeloid Malignancy
- Ruxolitinib
- +10 more
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Nov 7, 2022